News by Subject Medicine & Health

Public Release: 17-Feb-2017

AVN-322 is a safe orally bio-available potent and highly selective antagonist

Bentham Science Publishers
Public Release: 15-Feb-2017

What doesn't kill you makes you stronger

Sanford-Burnham Prebys Medical Discovery Institute
Public Release: 13-Feb-2017

Altmetric data analysis reveals how Parkinson's disease research affects the world

IOS Press
Public Release: 10-Feb-2017

Mitochondrial lipids as potential targets in early onset Parkinson's disease

VIB (the Flanders Institute for Biotechnology)
Public Release: 9-Feb-2017

Lost in translation: Parkinson's disease research undercut by study design

Yale University